The field leader Abiomed dropped 7% with Thoratec and Worldheart also suffering losses.
These companies leading the field with licensed advanced real products in the market are being marked down.
What hope for Ventracor with a $300m + market cap, no proven product, no licences and a moderately useful and common ventricle assist capacity if anyone ever uses it.
Tsk tsk!
VCR
ventracor limited
heart device sector battered overnight.
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)